title: European drug regulators publish their evaluation of rosiglitazone.
authors.forename: Susan
authors.initials: S
authors.lastname: Mayor
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005060:Europe; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone